A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars
Clinical trial NCT02246465 · UNKNOWN
Trial details
- NCT number
- NCT02246465
- Sponsor
- RXi Pharmaceuticals, Corp.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2017-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.